The First Drug For Postpartum Depression Could Be On Its Way

And researchers hope it could treat the condition in days.
Source: Science - The Huffington Post - Category: Science Source Type: news

Related Links:

A year after announcing a partnership with UNC, Cambridge-based pharma Sage Therapeutics (Nasdaq: SAGE) is preparing to open a National Patient Support Center with an AmerisourceBergen subsidiary. The goal, according to what Chief Business Officer Michael Cloonan said on an earnings call this week, is to address postpartum depression through a new, end-to-end patient support model – and to do it in the Triangle. “Oftentimes, patients with PPD do not know which health care professional they…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
MRI brain scans of young children show that conversations with adults can create...Read more on AuntMinnie.comRelated Reading: MRI shows the uniqueness of brain anatomy MRI ties high blood pressure to dementia risk MRI shows possible cause for attention woes after stroke MRI reveals effect of mild TBI on brain white matter MRI shows maternal depression meds affect babies' brains
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
A year after announcing a partnership with the University of North Carolina School of Medicine to develop postpartum depression treatments, Cambridge-based Sage Therapeutics is preparing to open a patient support center in Raleigh with an AmerisourceBergen subsidiary. The goal is to address postpartum depression through a new, end-to-end patient support model, Sage (Nasdaq: SAGE) Chief Business Officer Michael Cloonan said on an earnings call last week. The company is awaiting possible FDA approval…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
A year after announcing a partnership with the University of North Carolina, Massachusetts-based pharma Sage Therapeutics (Nasdaq: SAGE) is preparing to open a National Patient Support Center with an AmerisourceBergen subsidiary. The goal, according to what Chief Business Officer Michael Cloonan said on an earnings call last week, is to address postpartum depression through a new, end-to-end patient support model. “Oftentimes, patients with PPD do not know which health care professional they…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
A year after announcing a partnership with UNC, Cambridge-based pharma Sage Therapeutics (Nasdaq: SAGE) is preparing to open a National Patient Support Center with an AmerisourceBergen subsidiary. The goal, according to what Chief Business Officer Michael Cloonan said on an earnings call this week, is to address postpartum depression through a new, end-to-end patient support model – and to do it in the Triangle. “Oftentimes, patients with PPD do not know which health care professional they…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Women with intellectual and developmental disabilities have nearly double the rate of having another baby within a year Related items fromOnMedica NHS funding boost to support new mothers ’ mental health Maternal suicides remain a concern, report shows Valproate in pregnancy linked to raised autism risk Doctors urged to spot victims of trafficking Preterm birth risk higher after PTSD and major depression
Source: OnMedica Latest News - Category: UK Health Source Type: news
Maternal stress, anxiety and depression have been shown to directly affect fetal development, such as increasing arousal and influencing cortical processes (Kinsella&Monk,  2009). Specifically, maternal prenatal anxiety has been related to fetal movements (Kaitz, Mankuta, Rokem&Faraone, 2016) and to increased postnatal risk for neuro developmental disorders (Kinsella&Monk, 2009; Glover, 2011; 2015; Sheridan, et  al 2008, 2010). Some research indicates that both maternal anxiety and depression are co-morbid and one might influence the other.
Source: Journal of Affective Disorders - Category: Neurology Authors: Source Type: research
Abstract Psychosocial aspects of fertility, infertility, and assisted reproductive technology (ART) can significantly impact patients' sense of self-identity and personal agency, mental well-being, sexual and marital relationships, reproductive efficiency, compliance with treatment, and pregnancy outcomes. Research is needed to understand how stress, anxiety, depression, mood disorders, and psychotropic medications impact fertility and infertility treatment. The psychosocial implications of ART on our society include a shift toward older maternal age at conception, the complexities of third-party reproduction, and...
Source: The Medical Clinics of North America - Category: General Medicine Authors: Tags: Obstet Gynecol Clin North Am Source Type: research
ConclusionIn conclusion, it is thought that preparing the mothers for birth with birth preparation training in the antenatal period and imposing the necessary regulations in the delivery room for the mothers to have a positive birth experience are important in reducing postpartum depression risk.
Source: Sexual and Reproductive Healthcare - Category: Reproduction Medicine Source Type: research
CONCLUSIONS: The prevalence of prenatal anxiety and depression status was very common during pregnancy among pregnant women. Lower educational level and more physical occupations were associated with higher prevalence of anxiety and depression status. PMID: 30092662 [PubMed - as supplied by publisher]
Source: Journal of Reproductive and Infant Psychology - Category: Psychiatry & Psychology Tags: J Reprod Infant Psychol Source Type: research
More News: Depression | Postnatal Depression | Science